← Back to headlines
Lilly Receives Lone Sell Rating Ahead of Weight Loss Drug Price Cuts
Eli Lilly has received a rare 'sell' rating from HSBC, anticipating deeper price cuts for its weight loss drugs.
17 Mar, 20:10 — 17 Mar, 20:10
Sources
Showing 1 of 1 sources
